Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 30, 2023

SELL
$54.21 - $70.44 $3,848 - $5,001
-71 Reduced 43.83%
91 $6,000
Q3 2022

Oct 31, 2022

BUY
$53.02 - $135.75 $8,589 - $21,991
162 New
162 $9,000
Q1 2022

Apr 29, 2022

SELL
$55.72 - $67.12 $103,862 - $125,111
-1,864 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$54.02 - $63.83 $100,693 - $118,979
1,864 New
1,864 $109,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Prairie View Partners, LLC Portfolio

Follow Prairie View Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prairie View Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prairie View Partners, LLC with notifications on news.